Don't Suggest Xarelto for Most Coronary or Peripheral Artery Disease Patients

You'll hear debate about adding Xarelto (rivaroxaban) to aspirin for stable coronary artery disease (CAD) or peripheral artery disease (PAD).

In fact, there's a new Xarelto 2.5 mg tablet...approved by Health Canada to be given twice daily WITH low-dose aspirin to reduce CV events in patients with chronic CAD, with or without PAD.

You may hear reps call this the "vascular" dose of Xarelto...versus the 10, 15, and 20 mg doses for venous thromboembolism or atrial fib.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote